CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that financial results
for the company's fourth quarter and year ended December 31, 2016 will
be released on Wednesday, February 22, 2017. The management team will
host a conference call on Wednesday, February 22, 2017, at 4:30 p.m. ET
to discuss the company's financial results and recent developments. The
call can be accessed by dialing 1-855-420-0652 (domestic) or
1-484-365-2939 (international) five minutes prior to the start of the
call and providing the passcode 61272791.
The live, listen-only webcast of the conference call may be accessed by
visiting the investors' section of the company's website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the call and will be archived
on the company's website for two weeks following the call.
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI)
is a molecular information company dedicated to a transformation in
cancer care in which treatment is informed by a deep understanding of
the genomic changes that contribute to each patient's unique cancer. The
company offers a full suite of comprehensive genomic profiling assays to
identify the molecular alterations in a patient's cancer and match them
with relevant targeted therapies, immunotherapies and clinical trials.
Foundation Medicine's molecular information platform aims to improve
day-to-day care for patients by serving the needs of clinicians,
academic researchers and drug developers to help advance the science of
molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered
trademark of Foundation Medicine, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170206005255/en/
Foundation Medicine, Inc.
Kimberly Brown, 617-418-2215
Source: Foundation Medicine, Inc.
News Provided by Acquire Media